BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Wex Pharmaceuticals Inc. Drops 65% After Phase IIb/III Tectin (TM) Results Disappoint; To Cut Jobs

  March 6, 2006

   · 

  1 min read
• Policy

  Cubist Pharmaceuticals, Inc. Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss CUBICIN(R) sNDA

  March 6, 2006

   · 

  1 min read
• NationsHealth To Present At The Ninth Annual Lehman Brothers’ Global Healthcare Conference

  March 6, 2006

   · 

  1 min read
• Biotech Bay

  Nuvelo, Inc. Announces Upcoming Conference Calls, Webcasts And Conference Participation

  March 6, 2006

   · 

  1 min read
• Biotech Beach

  Edwards Lifesciences To Present At The SG Cowen & Co., LLC And Lehman Brothers Healthcare Conferences

  March 6, 2006

   · 

  1 min read
• Pharm Country

  Schering-Plough Corporation To Webcast CFO Robert J. Bertolini’s Presentation At Lehman Brothers Ninth Annual Global Healthcare Conference

  March 6, 2006

   · 

  1 min read
• BioMidwest

  Hyperthermia Could Turn Out To Be Among The Most Powerful Anticancer Weapons Yet

  March 6, 2006

   · 

  2 min read
• Business

  Infinity Pharmaceuticals, Inc. Announces Major Drug Discovery, Development And Commercialization Alliance In Oncology; Worth Up To $400 Million

  March 6, 2006

   · 

  5 min read
• Business

  CeNeS Pharmaceuticals PLC Signs Deal To Strengthen Intellectual Property For Morphine-6-Glucuronide (M6G) Synthesis And Manufacture

  March 6, 2006

   · 

  1 min read
• Policy

  Teva Pharmaceutical Industries Limited Announces Tentative Approval Of Topiramate Tablets, 50 mg

  March 6, 2006

   · 

  1 min read